Description
CHANGES RELATED TO EVERGREEN CLAUSE OPTION TO EXTEND PROVISION
Base award description: 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-08-09+$0= $0
- Mod P000012023-11-28+$0= $0
- Mod P000022024-11-22+$0= $0
- Mod P000032025-05-06+$0= $0
- Mod P000042025-09-03+$0= $0
- Mod P000052025-12-03+$0= $0
- Mod P000062026-05-21+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-08-09 | +$0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-11-28 | +$0 | $0 | 2024 PUBLIC LAW PRICING UPDATES |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-22 | +$0 | $0 | 2025 PUBLIC LAW PRICING UPDATES |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-05-06 | +$0 | $0 | PRODUCT ADDITION |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-09-03 | +$0 | $0 | LIFECYCLE UPDATE |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-03 | +$0 | $0 | 2026 PUBLIC LAW PRICING UPDATES |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-05-21 | +$0 | $0 | CHANGES RELATED TO EVERGREEN CLAUSE OPTION TO EXTEND PROVISION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J33MSDBJZMC6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N1034 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $72,362 | FY2026 |
| 36C24626N0782 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $72,563 | FY2026 |
| 36C24626N0690 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $54,422 | FY2026 |
| 36C24626N0637 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $36,281 | FY2026 |
| 36F79718D0593 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2018 |
| 36F79718D0020E | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2018 |
Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D058E | REVOLUTION MEDICINES, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0172 | LUNDBECK LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0195 | MILESTONE PHARMACEUTICALS USA, INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0165 | RECKITT BENCKISER LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79726D0118 | OMEROS CORPORATION | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79723D0171_3600 · retrieved 2026-09-26.